journal article·2013-08Open access

Antimicrobial peptides and induced membrane curvature: Geometry, coordination chemistry, and molecular engineering

Nathan W. Schmidt, Gerard C.L. Wong

Abstract

Short cationic, amphipathic antimicrobial peptides are multi-functional molecules that have roles in host defense as direct microbicides and modulators of the immune response. While a general mechanism of microbicidal activity involves the selective disruption and permeabilization of cell membranes, the relationships between peptide sequence and membrane activity are still under investigation. Here, we review the diverse functions that AMPs collectively have in host defense, and show that these functions can be multiplexed with a membrane mechanism of activity derived from the generation of negative Gaussian membrane curvature. As AMPs preferentially generate this curvature in model bacterial cell membranes, the selective generation of negative Gaussian curvature provides AMPs with a broad mechanism to target microbial membranes. The amino acid constraints placed on AMPs by the geometric requirement to induce negative Gaussian curvature are consistent with known AMP sequences. This 'saddle-splay curvature selection rule' is not strongly restrictive so AMPs have significant compositional freedom to multiplex membrane activity with other useful functions. The observation that certain proteins involved in cellular processes which require negative Gaussian curvature contain domains with similar motifs as AMPs, suggests this rule may be applicable to other curvature-generating proteins. Since our saddle-splay curvature design rule is based upon both a mechanism of activity and the existing motifs of natural AMPs, we believe it will assist the development of synthetic antimicrobials.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Antimicrobial Peptides and Activities · Biochemical and Structural Characterization · Immune Response and Inflammation

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (100+)

Show source-provided references
1. Antimicrobial peptides of multicellular organisms10.1038/415389a ↗
2. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?10.1038/nrmicro1098 ↗
3. Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by a-helical antimicrobial and cell non-selective membrane-lytic peptides10.1016/S0005-2736(99)00200-X ↗
4. Cationic peptides: a new source of antibiotics10.1016/S0167-7799(97)01156-6 ↗
5. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies10.1038/nbt1267 ↗
6. Mechanisms of antimicrobial peptide action and resistance10.1124/pr.55.1.2 ↗
7. A re-evaluation of the role of host defence peptides in mammalian immunity10.2174/1389203053027494 ↗
8. Ll-37, the only human member of the cathelicidin family of antimicrobial peptides10.1016/j.bbamem.2006.03.030 ↗
9. The roles of cathelicidin Ll-37 in immune defences and novel clinical applications10.1097/MOH.0b013e32831ac517 ↗
10. Criterion for amino acid composition of defensins and antimicrobial peptides based on geometry of membrane destabilization10.1021/ja200079a ↗
11. Arginine in A-defensins10.1074/jbc.M112.358721 ↗
12. Apd: the antimicrobial peptide database10.1093/nar/gkh025 ↗
13. Magainins, a class of antimicrobial peptides from xenopus skin: isolation, characterization of two active forms, and partial cdna sequence of a precursor10.1073/pnas.84.15.5449 ↗
14. Protegrins: leukocyte antimicrobial peptides that combine features of corticostatic defensins and tachyplesins10.1016/0014-5793(93)80175-T ↗
15. Defensins: antimicrobial peptides of innate immunity10.1038/nri1180 ↗
16. Primate defensins10.1038/nrmicro976 ↗
17. Mammalian defensins in the antimicrobial immune response10.1038/ni1206 ↗
18. Mouse paneth cell defensins: primary structures and antibacterial activities of numerous cryptdin isoforms10.1128/IAI.62.11.5040-5047.1994 ↗
19. A cyclic antimicrobial peptide produced in primate leukocytes by the ligation of two truncated a-defensins10.1126/science.286.5439.498 ↗
20. Indolicidin, a novel bactericidal tridecapeptide amide from neutrophils10.1016/S0021-9258(18)42830-X ↗
21. Amino acid sequence of Pr-3910.1111/j.1432-1033.1991.tb16442.x ↗
22. Mechanism of action of the antimicrobial peptide buforin Ii: buforin Ii kills microorganisms by penetrating the cell membrane and inhibiting cellular functions10.1006/bbrc.1998.8159 ↗
23. Three-dimensional solution structure of lactoferricin B, an antimicrobial peptide derived from bovine lactoferrin10.1021/bi972323m ↗
24. In vitro antibacterial properties of pexiganan, an analog of magainin10.1128/AAC.43.4.782 ↗
25. A multinational, randomized phase Iii trial of iseganan Hcl oral solution for reducing the severity of oral mucositis in patients receiving radiotherapy for head-and-neck malignancy10.1016/S0360-3016(03)01627-4 ↗
26. Omiganan pentahydrochloride (Mbi 226), a topical 12-amino-acid cationic peptide: spectrum of antimicrobial activity and measurements of bactericidal activity10.1128/AAC.48.8.3112-3118.2004 ↗
27. De novo designed synthetic mimics of antimicrobial peptides10.1016/j.copbio.2008.10.013 ↗
28. De novo design of antimicrobial polymers, foldamers, and small molecules: from discovery to practical applications10.1021/ar900036b ↗
29. De novo design of antibacterial b-peptides10.1021/ja992728p ↗
30. Antibiotics: non-haemolytic [beta]-amino-acid oligomers10.1038/35003742 ↗
31. Interplay among folding, sequence, and lipophilicity in the antibacterial and hemolytic activities of A/B-peptides10.1021/ja0666553 ↗
32. Helical peptoid mimics of magainin-2 amide10.1021/ja037320d ↗
33. De novo design of biomimetic antimicrobial polymers10.1073/pnas.082046199 ↗
34. New poly(phenylene ethynylene)S with cationic, facially amphiphilic structures10.1021/ja026607s ↗
35. Amphiphilic polymethacrylate derivatives as antimicrobial agents10.1021/ja044205+ ↗
36. Tuning the hemolytic and antibacterial activities of amphiphilic polynorbornene derivatives10.1021/ja045664d ↗
37. Peptide antimicrobial agents10.1128/CMR.00056-05 ↗
38. All-D-magainin: chirality, antimicrobial activity and proteolytic resistance10.1016/0014-5793(90)81351-N ↗
39. All-D amino acid-containing channel-forming antibiotic peptides10.1073/pnas.87.12.4761 ↗
40. Retro and retroenantio analogs of cecropin-melittin hybrids10.1073/pnas.92.8.3449 ↗
41. Androctonin, a hydrophilic disulphide-bridged non-haemolytic anti-microbial peptide: a plausible mode of action10.1042/0264-6021:3450653 ↗
42. Diversity of antimicrobial peptides and their mechanisms of action10.1016/S0005-2736(99)00198-4 ↗
43. Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by A-helical antimicrobial and cell non-selective membrane-lytic peptides10.1016/S0005-2736(99)00200-X ↗
44. Why and how are peptide-lipid interactions utilized for self-defense? Magainins and tachyplesins as archetypes10.1016/S0005-2736(99)00197-2 ↗
45. Relationship of membrane curvature to the formation of pores by magainin-210.1021/bi980539y ↗
46. Action of antimicrobial peptides: two-state model10.1021/bi000946l ↗
47. Bacterial membrane lipids in the action of antimicrobial agents10.1002/psc.1319 ↗
48. Phospholipids in animal eukaryotic membranes: transverse asymmetry and movement10.1042/bj2940001 ↗
49. Membrane lipids: where they are and how they behave10.1038/nrm2330 ↗
50. Divalent metal ion triggered activity of a synthetic antimicrobial in cardiolipin membranes10.1021/ja9067063 ↗
51. Synthetic antimicrobial oligomers induce a composition-dependent topological transition in membranes10.1021/ja072310o ↗
52. Molecular basis for membrane selectivity of an antimicrobial peptide, magainin 210.1021/bi00010a034 ↗
53. Basis for selectivity of cationic antimicrobial peptides for bacterial versus mammalian membranes10.1074/jbc.M507042200 ↗
54. Effect of cholesterol on the interaction of the amphibian antimicrobial peptide Dd K with liposomes10.1016/j.peptides.2007.10.028 ↗
55. Interaction of melittin with membrane cholesterol: a fluorescence approach10.1529/biophysj.104.043596 ↗
56. Universal behavior of membranes with sterols10.1529/biophysj.105.067652 ↗
57. Does cholesterol play a role in the bacterial selectivity of antimicrobial peptides?
58. Crystallization of antimicrobial pores in membranes: magainin and protegrin10.1016/S0006-3495(00)76448-4 ↗
59. Barrel-stave model or toroidal model? A case study on melittin pores10.1016/S0006-3495(01)75802-X ↗
60. Membrane pores induced by magainin†10.1021/bi9620621 ↗
61. Phosphate-mediated arginine insertion into lipid membranes and pore formation by a cationic membrane peptide from solid-state NMR10.1021/ja072511s ↗
62. Msi-78, an analogue of the magainin antimicrobial peptides, disrupts lipid bilayer structure via positive curvature strain10.1016/S0006-3495(03)70031-9 ↗
63. Interaction of antimicrobial dermaseptin and its fluorescently labeled analogs with phospholipid membranes10.1021/bi00164a017 ↗
64. Spectrum of antimicrobial activity and assembly of dermaseptin-B and its precursor form in phospholipid membranes10.1021/bi00202a014 ↗
65. Orientation of cecropin a helices in phospholipid bilayers determined by solid-state NMR spectroscopy10.1016/S0006-3495(99)77145-6 ↗
66. Interaction of the mammalian antibacterial peptide cecropin P1 with phospholipid vesicles10.1021/bi00036a021 ↗
67. Energetics of pore formation induced by membrane active peptides10.1021/bi036153r ↗
68. Conformation of peptides in lipid membranes studied by X-ray grazing incidence scattering10.1529/biophysj.104.040667 ↗
69. Cathelicidin peptides inhibit multiply antibiotic-resistant pathogens from patients with cystic fibrosis10.1128/AAC.45.10.2838-2844.2001 ↗
70. Congeners of Smap29 kill ovine pathogens and induce ultrastructural damage in bacterial cells10.1128/AAC.45.11.3256-3261.2001 ↗
71. Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections10.1086/429323 ↗
72. Interaction of antimicrobial peptide protegrin with biomembranes10.1073/pnas.0934731100 ↗
73. Vesicle budding induced by a pore-forming peptide10.1021/ja9059014 ↗
74. Binding of tachyplesin I to DNA revealed by footprinting analysis: significant contribution of secondary structure to DNA binding and implication for biological action10.1021/bi00126a022 ↗
75. Structural and DNA-binding studies on the bovine antimicrobial peptide, indolicidin: evidence for multiple conformations involved in binding to membranes and DNA10.1093/nar/gki725 ↗
76. Mechanism of antimicrobial action of indolicidin10.1111/j.1574-6968.1998.tb12896.x ↗
77. Mechanisms of action on Escherichia coli of cecropin P1 and Pr-39, two antibacterial peptides from pig intestine10.1128/IAI.61.7.2978-2984.1993 ↗
78. Interaction of human defensins with Escherichia coli. Mechanism of bactericidal activity10.1172/JCI114198 ↗
79. Sublethal concentrations of pleurocidin-derived antimicrobial peptides inhibit macromolecular synthesis in Escherichia coli10.1128/AAC.46.3.605-614.2002 ↗
80. Monocyte-chemotactic activity of defensins from human neutrophils10.1172/JCI114394 ↗
81. Identification of defensin-1, defensin-2, and Cap37/azurocidin as t-cell chemoattractant proteins released from interleukin-8-stimulated neutrophils10.1074/jbc.271.6.2935 ↗
82. Human neutrophil defensins selectively chemoattract naive T and immature dendritic cells10.1189/jlb.68.1.9 ↗
83. B-defensins: linking innate and adaptive immunity through dendritic and T Cell Ccr610.1126/science.286.5439.525 ↗
84. Identification of a novel, multifunctional ß-defensin (human ß-defensin 3) with specific antimicrobial activity10.1007/s004410100433 ↗
85. Human ß-defensin 4: a novel inducible peptide with a specific salt-sensitive spectrum of antimicrobial activity10.1096/fj.00-0865fje ↗
86. Ll-37, the neutrophil granule–and epithelial cell–derived cathelicidin, utilizes formyl peptide receptor–like 1 (Fprl1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells10.1084/jem.192.7.1069 ↗
87. Immunomodulatory activities of small host defense peptides10.1128/AAC.49.5.1727-1732.2005 ↗
88. Chemoattractant properties of Pr-39, a neutrophil antibacterial peptide10.1002/jlb.61.5.624 ↗
89. Mouse cathelin-related antimicrobial peptide chemoattracts leukocytes using formyl peptide receptor-like 1/mouse formyl peptide receptor-like 2 as the receptor and acts as an immune adjuvant10.4049/jimmunol.174.10.6257 ↗
90. Neutrophil defensins induce histamine secretion from mast cells: mechanisms of action10.4049/jimmunol.163.2.947 ↗
91. Evaluation of the effects of peptide antibiotics human B-defensins-1/-2 and Ll-37 on histamine release and prostaglandin d2 production from mast cells10.1002/1521-4141(200104)31:4<1066::AID-IMMU1066>3.0.CO;2-# ↗
92. Effect of defensins on interleukin-8 synthesis in airway epithelial cells
93. Neutrophil defensins stimulate the release of cytokines by airway epithelial cells: modulation by dexamethasone10.1007/PL00000282 ↗
94. Structure-function relationships among human cathelicidin peptides: dissociation of antimicrobial properties from host immunostimulatory activities10.4049/jimmunol.174.7.4271 ↗
95. The human antimicrobial peptide Ll-37 is a multifunctional modulator of innate immune responses10.4049/jimmunol.169.7.3883 ↗
96. Lipopolysaccharide (endotoxin)-host defense antibacterial peptides interactions: role in bacterial resistance and prevention of sepsis10.1016/j.bbamem.2006.05.017 ↗
97. Bovine and human cathelicidin cationic host defense peptides similarly suppress transcriptional responses to bacterial lipopolysaccharide10.1189/jlb.0106048 ↗
98. An angiogenic role for the human peptide antibiotic Ll-37/Hcap-1810.1172/JCI17545 ↗
99. Induction of keratinocyte migration via transactivation of the epidermal growth factor receptor by the antimicrobial peptide Ll-3710.4049/jimmunol.175.7.4662 ↗
100. In vitro and in vivo wound healing-promoting activities of human cathelicidin Ll-3710.1038/sj.jid.5701043 ↗